These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1873857)

  • 1. Human cutaneous malignant melanoma as a model for cancer.
    Clark WH
    Cancer Metastasis Rev; 1991 Jun; 10(2):83-8. PubMed ID: 1873857
    [No Abstract]   [Full Text] [Related]  

  • 2. Thin cutaneous malignant melanoma and the MIN terminology.
    Skov L; Clemmensen O; Baadsgaard O
    Lancet; 1997 Nov; 350(9087):1264-5. PubMed ID: 9357402
    [No Abstract]   [Full Text] [Related]  

  • 3. On the terminology of cutaneous melanoma.
    Bondi R; Urso C
    Am J Dermatopathol; 1989 Feb; 11(1):93-4. PubMed ID: 2916745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Meaning of the concept "local recurrence" following surgical treatment of malignant melanoma of the skin].
    Anisimov VV
    Vopr Onkol; 1985; 31(1):32-8. PubMed ID: 3976193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnosis and therapy of cutaneous melanoma in situ.
    Massi D
    Cancer; 1996 Sep; 78(5):1140-2. PubMed ID: 8780556
    [No Abstract]   [Full Text] [Related]  

  • 6. Whither malignant melanoma in situ?
    del Junco GW
    Am J Dermatopathol; 1984; 6 Suppl():101-2. PubMed ID: 6528899
    [No Abstract]   [Full Text] [Related]  

  • 7. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
    Roncati L; Pusiol T; Piscioli F
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster analysis of serum proteins in malignant cutaneous melanoma: search for disease markers.
    Ragazzi E; Vogliardi S; Allegri G; Costa CV; Lise M; Rossi CR; Seraglia R; Traldi P
    Rapid Commun Mass Spectrom; 2003; 17(13):1511-5. PubMed ID: 12820221
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma in situ: an oxymoron whose time has come.
    Mihm MC; Murphy GF
    Hum Pathol; 1998 Jan; 29(1):6-7. PubMed ID: 9445127
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant melanoma.
    CA Cancer J Clin; 1984; 34(6):353-4. PubMed ID: 6437628
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary malignant melanoma--conceptual differences.
    Fusaro RM; Lynch HT
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):833-4. PubMed ID: 4078084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification and nomenclature of malignant melanomas of the skin].
    Schmoeckel C
    Dtsch Med Wochenschr; 1983 Feb; 108(6):231-2. PubMed ID: 6825599
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanoma and terminology for melanocytic intraepidermal neoplasia.
    Slater D
    Lancet; 1998 Feb; 351(9101):522-3. PubMed ID: 9482473
    [No Abstract]   [Full Text] [Related]  

  • 14. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.
    J Clin Pathol; 1997 Mar; 50(3):202-5. PubMed ID: 9155669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanomas.
    Mishima Y
    Lancet; 1968 Jun; 1(7555):1314-5. PubMed ID: 4172172
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin.
    Eves P; Layton C; Hedley S; Dawson RA; Wagner M; Morandini R; Ghanem G; Mac Neil S
    Br J Dermatol; 2000 Feb; 142(2):210-22. PubMed ID: 10730751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.
    Jiang L; Lv X; Li J; Li J; Li X; Li W; Li Y
    Acta Histochem; 2012 Oct; 114(6):582-8. PubMed ID: 22130252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel.
    Cook MG; Clarke TJ; Humphreys S; Fletcher A; McLaren KM; Smith NP; Stevens A; Theaker JM; Melia J
    Histopathology; 1996 Jun; 28(6):497-512. PubMed ID: 8803593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.
    Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM
    Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verrucous malignant melanoma.
    Schwartz RA; Hill WE; Hansen RC; Fleishman JS
    J Dermatol Surg Oncol; 1980 Sep; 6(9):719-24. PubMed ID: 7419785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.